The DFA Discussion, page-63

My expectation/hope for Monday:
DFA agree to waive current obligations pending ShORe result.

ShORe trial unmasked this week.

Data analysed this week.

Full announcement Monday.

need >4 letters for share price to hold. Smaller revenue opportunity but its not game over if we can get >4 letters.

Next step would then be FDA approval for approval with one phase 3 trial (can be considered based on size of phase 2 trials) and a licensing partner.

Binary outcome but above sums up what I’m reading from multiple brokers in a best case scenario.